Sanctions-hit Iran struggles to make cancer drugs: Report Medical Dialogues Bureau7 March 2020 9:00 AM ISTIran: A lab-coated technician leans over a bioreactor at an Iranian pharmaceutical plant producing cancer drugs -- a tall order since equipment...
Sun pharma, Dr Reddys, others deny allegations of price fixing in US Garima16 May 2019 9:35 AM ISTIn separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit Farhat Nasim14 May 2019 4:57 PM ISTMumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
AstraZeneca Q1 sales beat estimates on cancer drugs Garima28 April 2019 9:15 AM ISTAstraZeneca, fresh off an oncology deal with Japan's Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009,...
NPPA caps trade margins to 30 percent for 42 cancer drugs Meghna A Singhania28 Feb 2019 9:20 AM ISTAs per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it...
NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report Meghna A Singhania21 Feb 2019 3:13 PM ISTHowever, the move is likely to stimulate retailers to spend more as trade margins on drugs that have somehow bypassed the list and the retailers may...
Pfizer quarterly profit in line, touts pipeline of future products Medical Dialogues Bureau31 Jan 2019 9:05 AM ISTOn a call with analysts, new Chief Executive Albert Bourla said Pfizer had "the best pipeline in our history," and predicted that the company would...
Johnson & Johnson profit beats, lifts forecast on cancer drug demand Medical Dialogues Bureau17 Oct 2018 9:10 AM ISTJohnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sept 2017 10:17 AM ISTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 12:25 PM ISTLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...
